{
  "thread": {
    "uuid": "132f691dc5b554cef3a6d1647c8df493ca654f92",
    "url": "https://www.abnewswire.com/pressreleases/increasing-prevalence-of-chronic-diseases-driving-pharmaceutical-excipients-market-at-68-cagr-by-2031_717327.html",
    "site_full": "www.abnewswire.com",
    "site": "abnewswire.com",
    "site_section": "http://www.abnewswire.com/pressreleases/feed",
    "site_categories": [
      "photography",
      "hobbies_and_interests"
    ],
    "section_title": "ABNewswire",
    "title": "Increasing Prevalence of Chronic Diseases Driving Pharmaceutical Excipients Market at 6.8% CAGR by 2031",
    "title_full": "Increasing Prevalence of Chronic Diseases Driving Pharmaceutical Excipients Market at 6.8% CAGR by 2031",
    "published": "2024-10-18T01:30:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 33951,
    "domain_rank_updated": "2024-10-15T00:00:00.000+03:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "132f691dc5b554cef3a6d1647c8df493ca654f92",
  "url": "https://www.abnewswire.com/pressreleases/increasing-prevalence-of-chronic-diseases-driving-pharmaceutical-excipients-market-at-68-cagr-by-2031_717327.html",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "admin",
  "published": "2024-10-18T01:30:00.000+03:00",
  "title": "Increasing Prevalence of Chronic Diseases Driving Pharmaceutical Excipients Market at 6.8% CAGR by 2031",
  "text": "Pharmaceutical Excipients Market size was valued at USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).The pharmaceutical enterprise has step by step identified binders which will assist energetic pharmaceutical substances in achieving higher functionality and imparting a competitive benefit. Additionally, with the growth in the manufacturing of prescription drugs, the requirement for binders is expected to increase, propelling the market.\nRequest your free sample PDF of the report today: https://www.skyquestt.com/sample-request/pharmaceutical-excipients-market\nBusiness Verticals Improved Competitive Landscape in the Pharmaceutical Excipients Market\nThe pharmaceutical excipients market presents a dynamic competitive environment driven by interactions between leading pharmaceutical excipient manufacturers, generic companies, organizations a contractor (CMOs), and emerging specialized players.\nMajor Excipients Manufacturers: Global leaders such as BASF, DuPont, Roquette and others dominate this segment, spending huge resources investing in R&D and expanding their product range. These large manufacturers deal with small pharmaceuticals and biologics, from binder supplements to disruption. Their competitive edge lies in their ability to develop new multifunctional excipients that improve drug efficacy, bioavailability and meet stringent regulatory standards. These companies are often with pharmaceuticals teams to work together to develop customized solutions, long-term contracts and market dominance.\nGeneric Companies: Manufacturers of generic drugs, such as Teva Pharmaceuticals and Mylan, rely on complementary solutions that cost less and fly more effectively to remain competitive. Adjuvants are increasingly important to ensure that generic drug products match the quality and activity of the branded drug. These companies tend to prioritize partnerships with smaller manufacturers that can offer high-quality products at competitive prices.\nFor a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/pharmaceutical-excipients-market\nCompetitive Landscape an Overview of the Pharmaceutical Excipients Market\nThe competitive environment in the pharmaceutical excipients market is characterized by intense competition among established players, technological advancements, and increasing emphasis on quality and regulatory compliance in the market growth is driven by innovation, collaboration and growing demand for pharmaceutical excipients that meet the evolving needs of pharmaceutical products.\nTechnological Innovation and R&D: The ability to develop new products to help deliver functional benefits such as increased drug solubility, improved bioavailability, and delivery time. Companies offering high-performance innovative adjuvants are well positioned to gain market share, especially as the pharmaceutical excipients industry moves toward more complex drugs.\nStrategic Cooperation and Partnership\nOctober 2023: Clariant, a leading pharmaceutical company focused on sustainability, launched its portfolio of high-performance formulation solutions to support safe and effective pharmaceuticals manufacturing. In addition, Clariant Health Care addresses active pharmaceutical (API) delivery & bioavailability challenges and expanded its range of business auxiliaries.\nSeptember 2023: Roquette, a company that focuses on plant-based products and provides pharmaceutical and nutritional supplements, offers three new complementary products to its solution portfolio of active liquid formulations cooling.\nThis report covers following segments:\nA. Product\nOrganic Chemicals\nInorganic Chemicals\nOther Chemicals\nB. Functionality\nFillers & Diluents\nSuspending & Viscosity Agents\nCoating Agents\nBinders\nFlavoring Agents & Sweeteners\nDisintegrants\nColorants\nLubricants & Glidants\nPreservatives\nEmulsifying Agents\nOther Functionalities\nC. Formulation\nOral Formulations\nTopical Formulations\nParenteral Formulations\nOther Formulations\nD. Functionality Application\nStabilizers\nTaste Masking\nModified Release\nSolubility & Bioavailability Enhancement\nOther Functionality Applications\nThis report covers following key players:\nBASF SE\nAshland Inc.\nEvonik Industries AG\nKerry Group PLC\nRoquette Frères\nMerck KGaA\nAssociated British Foods PLC\nADM\nWacker Chemie AG\nAir Liquide\nDow\nLubrizol Corporation\nColorcon\nDFE Pharma\nInnophos\nJ. Rettenmaier & Söhne GmbH\nMeggle GmbH & Co. KG\nFuji Chemical Industries Co., Ltd.\nCorel Pharma Chem\nBiogrund GmbH\nNitika Pharmaceutical Specialties Pvt. Ltd.\nR.T. Vanderbilt Holding Company, Inc.\nBeneo\nPurchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/pharmaceutical-excipients-market\nCatalyzing the Future of Pharmaceutical Excipients Market\nThe pharmaceutical excipients market is about to enjoy robust growth due to the demand for novel drug formulations and advanced delivery systems increases. Excipients, which play an important position in drug stability, bioavailability, and patient compliance, are gaining extra attention from pharmaceutical producers. With innovations in biologics, sustained-release formulations, and personalized medicine, excipient manufacturers are poised to expand their market share by developing new, multifunctional excipients. As R&D in drug development continues to advance, the pharmaceutical excipients market will remain an essential component in the future of healthcare.\nTo read the full report, please visit: https://www.skyquestt.com/report/pharmaceutical-excipients-market\nMedia Contact\nCompany Name: Skyquest Technology\nContact Person: Mr. Jagraj Singh\nEmail: Send Email\nPhone: +1 351-333-4748\nAddress:1 Apache Way, Westford,\nCountry: United States\nWebsite: https://www.skyquestt.com/report/pharmaceutical-excipients-market",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Economy, Business and Finance",
    "Health",
    "Science and Technology"
  ],
  "ai_allow": true,
  "webz_reporter": false,
  "external_links": [
    "https://www.skyquestt.com/report/pharmaceutical-excipients-market",
    "https://www.skyquestt.com/sample-request/pharmaceutical-excipients-market",
    "https://www.skyquestt.com/buy-now/pharmaceutical-excipients-market",
    "https://www.skyquestt.com/speak-with-analyst/pharmaceutical-excipients-market",
    "https://skyquestt.com/buy-now/pharmaceutical-excipients-market",
    "https://skyquestt.com/sample-request/pharmaceutical-excipients-market",
    "https://skyquestt.com/speak-with-analyst/pharmaceutical-excipients-market",
    "https://skyquestt.com/report/pharmaceutical-excipients-market"
  ],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": "132f691dc5b554cef3a6d1647c8df493ca654f92",
    "first_syndicated": true
  },
  "rating": null,
  "crawled": "2024-10-18T01:53:26.604+03:00",
  "updated": "2024-10-18T01:53:26.604+03:00"
}